Enfusion

Enfusion Share Buybacks

Delisted

The Share Buybacks of Enfusion (ENFN) as of Nov 7, 2026 is -60.45 M USD. In the previous year, Share Buybacks was -7.96 M USD — a change of 659.48% (lower).

Share Buybacks

-60.45 MUSD

YoY

659.48%

Last updated:

Share Buybacks of Enfusion is 2023 -60.45 M USD. Share Buybacks of Enfusion was 2022 -7.96 M USD. It decreases by 659.48% lower compared to the previous year.

The Enfusion Share Buybacks history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Share Buybacks
Date
Share Buybacks
Jan 1, 2019
-57.45 M USD
Jan 1, 2020
-76.63 M USD
Jan 1, 2021
-87.85 M USD
Jan 1, 2022
-7.96 M USD
Jan 1, 2023
-60.45 M USD
The Enfusion Share Buybacks history
YEARShare BuybacksYoY
-60.45 MUSD+659.48%
-7.96 MUSD-90.94%
-87.85 MUSD+14.63%
-76.63 MUSD+33.39%
-57.45 MUSD—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Enfusion Stock analysis

What does Enfusion do? Enfusion Inc. generates revenue through cloud-native multi-tenant software solutions tailored for alternative and institutional investment managers. Its core products include the Portfolio Management System (PMS), Order and Execution Management System (OEMS), Accounting/General Ledger System, and Enfusion Analytics System, which collectively enable real-time investment decision-making. The company serves investment managers who require integrated systems for the full investment lifecycle, with PMS constructing and rebalancing portfolios while generating a real-time investment book of record, and OEMS facilitating electronic trade order communication for portfolio managers, traders, compliance teams, and analysts. The company's solution integrates technology-powered managed services to drive insights and control over investment operations. Enfusion's end-to-end functionality supports the entire investment process, from portfolio construction to trade execution, with PMS and OEMS operating in tandem to provide a seamless workflow. Investment managers across alternative and institutional segments purchase these integrated systems to enhance operational efficiency and decision-making capabilities. Enfusion's software is designed to serve the full investment lifecycle, with its systems integrated to provide a unified platform for portfolio management, order execution, accounting, and analytics. The company's revenue model is based on delivering these comprehensive solutions to investment managers who rely on real-time data and integrated workflows to manage their operations effectively. Enfusion is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Enfusion stock

Share Buybacks of Enfusion is -60.45 M USD in 2023.

Share Buybacks of Enfusion changed from -7.96 M USD to -60.45 M USD, representing a 659.48% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Share Buybacks Enfusion since 2006 – with annual values, charts, and detailed analysis.

Share buybacks represent the cash spent repurchasing the company's own shares. Buybacks reduce shares outstanding and can increase EPS.

Share Buybacks's USD is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Share Buybacks's Enfusion historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Cash Flow — Enfusion

All Key Metrics — Enfusion